Loading…
Tuesday October 1, 2024 2:00pm - 2:45pm EDT
The past year witnessed a substantial influx of investment into the neuroscience sector, culminating in several high-value deals during the fourth quarter of 2023. The trend continues into this year, with several companies aiming to delve deeper into neuroscience and psychiatric disease. What lies ahead? Join this panel discussion as experts examine emerging trends, breakthroughs, and disease targets within the neuropharmaceutical field, providing valuable insights into the future direction of research and development in this area.
 
Moderated by: Fierce Editorial Team
Speakers
avatar for Blake Mandell

Blake Mandell

Co-founder and CEO, Transcend Therapeutics
Blake Mandell is the co-founder and CEO of Transcend Therapeutics, a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Transcend's mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Blake was named to Forbes' "30 under 30" and has lectured at University of Pennsylvania and Brown University... Read More →
avatar for Kabir Nath

Kabir Nath

CEO, Compass Pathways
Experienced leader in health care industry, committed to revolutionising mental health care. Kabir Nath has approximately thirty years of experience in the biopharmaceutical and medical device industry. Prior to joining Compass, Kabir was Senior Managing Director of global pharmaceuticals... Read More →
avatar for Craig Thompson

Craig Thompson

CEO, Cerevance
Craig Thompson, CEO of Cerevance, brings over 25 years of commercial and marketing leadership experience in the biotech and pharmaceutical industries. Prior to joining Cerevance, he was the president and CEO of Neurana Pharmaceuticals, a private company focused on the treatment of... Read More →
Tuesday October 1, 2024 2:00pm - 2:45pm EDT

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link